Emerging Oncogenic Viruses

30 May to 3 June 2012

Additional sponsor

Fondazione Veronesi

Background Information

Approximately 20% of all human cancers worldwide have been associated with infectious agents. This percentage is likely to be higher in low-resource countries where, due to socio-economic conditions, infections are more frequent and healthcare surveillance is less available than in high-resource countries. Based on a vast number of biological and epidemiological studies, the International Agency for Research on Cancer (IARC) has classified 6 viruses and one bacterium as human carcinogens-i.e. high-risk mucosal human papillomavirus (HPV) types, hepatitis C virus (HCV), hepatitis B virus, Human T-lymphotropic virus type I (HTLV-1), Epstein-Barr virus (EBV), Kaposi sarcoma-associated virus (KSHV) and the bacterium Helicobacter pylori.

The 20% estimate of pathogen-associated cancers may be rather low, and new evidence supports the involvement of additional infectious agents in human carcinogenesis. A recently discovered human polyomavirus, Merkel Cell polyomavirus, is associated with a rare tumour, Merkel cell sarcoma. Early epidemiological studies suggest that infection with MCPyV is widespread in humans, and additional tumour associations may yet be discovered. Ongoing studies concerning a subgroup of HPV types that infect the skin suggest their involvement, together with ultraviolet radiation (or solar exposure), in the development of non-melanoma skin cancer (NMSC) in normal populations.

This meeting is a joint IARC/DKFZ initiative that will focus on discussions and the critical evaluation of epidemiology, immunology and biology of cancer-associated viruses. The meeting programme emphasises new HPV-related cancers and newly discovered human polyomaviruses, although advances concerning other pathogens will be incorporated as they arise.